Added to YB: 2026-07-02
Pitch date: 2026-06-30
MRK.DE [neutral]
Merck KGaA
-1.67%
current return
Author Info
Lux Opes Research covers European companies. Lots of them. Sign up for the newsletter.
Company Info
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
Market Cap
EUR 63.8B
Pitch Price
EUR 146.95
Price Target
N/A
Dividend
1.50%
EV/EBITDA
12.72
P/E
25.20
EV/Sales
3.44
Sector
Pharmaceuticals
Category
special_situation
Merck (MRK Germany): Bio-Techne strengthens the part of the portfolio with the greatest long-term potential
MRK.DE (update): Acquiring Bio-Techne for $73/sh, $11.3B EV (~23x EV/EBITDA, 17.5x post-synergies). Strengthens Life Science division—81% consumables/recurring rev, strong in cell therapy. Adds 19.9% Wilson Wolf stake + buyout option post-FY27. 2nd-largest deal in co history; cost synergies + better cash conversion over 3yrs.
Read full article (2 min)